You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Altis 522

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Incorporation of Protein Induced by Vitamin K Absence or

Completed
  • Cancer of Liver
  • No intervention
  • Hangzhou, Zhejiang, China
    Affiliated Hangzhou First People's Hospital, Zhejiang University
Jun 8, 2023

Postoperative Peritoneal Metastasis After Hepatocellular

Completed
  • Peritoneal Metastasis
  • Peritoneal Metastasis
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 25, 2023

Cystic Fibrosis Trial in Baltimore (VX-522)

Recruiting
  • Cystic Fibrosis
  • VX-522
  • Baltimore, Maryland
    Baltimore - Early Phase Clinical Unit
Jan 4, 2023

Stress Urinary Incontinence Trial in United States (Desara® One Single Incision Sling, Desara® Blue Transobturator Sling)

Recruiting
  • Stress Urinary Incontinence
  • Desara® One Single Incision Sling
  • Desara® Blue Transobturator Sling
  • Phoenix, Arizona
  • +14 more
Aug 10, 2022

St.Jude Medical Cardiac Lead Assessment Study

Completed
Has Results
  • Externalized Conductors
  • +2 more
  • Implanted with one or more of the following SJM leads: Riata leads, RiataST leads, Durata leads, and QuickSite/QuickFlex leads
  • Birmingham, Alabama
  • +44 more
Jul 29, 2021

TriQuik Invitro Diagnostic Device

Not yet recruiting
  • To Demonstrate Clinical Performance of the TriQuik Invitro Diagnostic Device
  • TriQuik IVD
  • (no location specified)
Jan 11, 2023

Breast Cancer Trial in Guangzhou (Chidamide Plus Toripalimab Plus Paclitaxel)

Recruiting
  • Breast Cancer
  • Chidamide Plus Toripalimab Plus Paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 19, 2023

Stress Urinary Incontinence, Pelvic Floor Disorders Trial in United States (RP sling placement, SIS placement)

Recruiting
  • Stress Urinary Incontinence
  • Pelvic Floor Disorders
  • RP sling placement
  • SIS placement
  • Washington, District of Columbia
  • +5 more
Dec 21, 2022

Acute Kidney Injury, Fluid Overload Trial in United States (Carpediem System)

Recruiting
  • Acute Kidney Injury
  • Fluid Overload
  • Carpediem System
  • Iowa City, Iowa
  • +5 more
Sep 5, 2022

Triple Negative Breast Tumors Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab
  • +7 more
  • Scottsdale, Arizona
  • +192 more
Jul 8, 2022

Stress Urinary Incontinence Trial in Worldwide (Altis Single Incision Sling System)

Completed
  • Stress Urinary Incontinence
  • Altis Single Incision Sling System
  • Bron, France
  • +12 more
Sep 23, 2021

Acute Instabilities Thoracic, Lumbar and Sacral Spine, Chronic Instabilities Thoracic, Lumbar and Sacral Spine, Deformities of

Terminated
Has Results
  • Acute Instabilities Thoracic, Lumbar and Sacral Spine
  • +2 more
  • TRANSITION
  • REVERE
  • Fort Wayne, Indiana
    Fort Wayne Orthopaedics
Feb 18, 2021

Degenerative Spondylolisthesis, Pseudoarthrosis Trial in United States (Dynesys Spinal System)

Terminated
Has Results
  • Degenerative Spondylolisthesis
  • Pseudoarthrosis
  • Dynesys Spinal System
  • Belleville, Illinois
  • +8 more
Jan 17, 2020

COVID19 Trial (Hydroxychloroquine and azithromycin treatment, conventional management of patients)

Withdrawn
  • COVID19
  • Hydroxychloroquine and azithromycin treatment
  • conventional management of patients
  • (no location specified)
Nov 18, 2020

Herpes Zoster Trial in Qixian (One shot of the zoster vaccine, One shot of the varicella vaccine, one shot of )

Unknown status
  • Herpes Zoster
  • One shot of the zoster vaccine
  • +2 more
  • Qixian, Henan, China
    Henan Provincial Center for Disease Control and Prevention
Aug 27, 2019

Genuine Stress Incontinence Trial in Athens (Altis tape, TVTO)

Unknown status
  • Genuine Stress Incontinence
  • Altis tape
  • TVTO
  • Athens, Attiki, Greece
    Aretaieio University Hospital
Apr 22, 2018

Diabetic Nephropathies Trial (serum immunoglobulin G level)

Unknown status
  • Diabetic Nephropathies
  • serum immunoglobulin G level
  • (no location specified)
Jul 7, 2017

Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study

Completed
  • Pinnacle Metal-on-Metal
  • +4 more
  • Pinnacle Metal-on Metal
  • Orange, California
  • +7 more
Sep 23, 2016

ASR-XL Metal-on-Metal 522 Post-Market Surveillance Study

Completed
  • Adverse Local Tissue Reaction
  • Total Hip Arthroplasty
  • ASR-XL Metal-on-Metal
  • Fort Collins, Colorado
  • +6 more
Sep 23, 2016

Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,

Terminated
Has Results
  • Recurrent Renal Cell Cancer
  • +3 more
  • Marysville, California
  • +4 more
Apr 28, 2014

Malignant Melanoma Trial in Pittsburgh (MEDI-522)

Completed
  • Malignant Melanoma
  • MEDI-522
  • Pittsburgh, Pennsylvania
    University Of Pittsburgh Cancer Institute
Mar 13, 2012

Psoriasis Trial in Canada, United States (MEDI-522, Placebo)

Completed
  • Psoriasis
  • Little Rock, Arkansas
  • +19 more
Apr 2, 2009

Cancer Trial in Villejuf (MEDI-522)

Completed
  • Cancer
  • Villejuf, France
    Institut Gustave Roussy
Jan 28, 2009

Melanoma, Malignant Metastatic Melanoma Trial in United States (MEDI--522, Integrin + Dacarbazine)

Completed
  • Melanoma
  • Malignant Metastatic Melanoma
  • MEDI--522
  • Integrin + Dacarbazine
  • Scottsdale, Arizona
  • +24 more
Jan 14, 2008

Prostate Cancer Trial in Worldwide (MEDI-522, Docetaxel + Prednisone* + Zoledronic Acid)

Completed
  • Prostate Cancer
  • MEDI-522
  • Docetaxel + Prednisone* + Zoledronic Acid
  • Hoover, Alabama
  • +56 more
Jan 11, 2008